Logo-ps

 

Follower of ICMJE

Powered by:
Review COVID-19

1. COVID-19: A Devastating Pandemic
Punet Kumar* ORCID, Md Iftekhar Ahmad ORCID, Sangam Singh ORCID
Pharm Sci. 2020;26(Suppl 1): S3-S11. doi: 10.34172/PS.2020.34
Scopus ID: 85097274657    
Article
PDF
XML
Cited By:
3
4
Commentary COVID-19

2. Prophylactic Use of Chloroquine May Impair Innate Immune System Response against SARS-Cov-2
Hamid Soraya* ORCID
Pharm Sci. 2020;26(Suppl 1): S78-S79. doi: 10.34172/PS.2020.29
Scopus ID: 85086764367    
Article
PDF
XML
Cited By:
2
1
Research Article COVID-19

3. Molecular Docking of Novel 5-O-benzoylpinostrobin Derivatives as SARS-CoV-2 Main Protease Inhibitors
Mohammad Rizki Fadhil Pratama ORCID, Hadi Poerwono ORCID, Siswandono Siswodihardjo* ORCID
Pharm Sci. 2020;26(Suppl 1): S63-S77. doi: 10.34172/PS.2020.57
Scopus ID: 85097303712    
Article
PDF
XML
Cited By:
7
2
Research Article COVID-19

4. In Silico Drug Repurposing of Penicillins to Target Main Protease Mpro of SARS-CoV-2
Baby Krishnaprasad ORCID, Swastika Maity ORCID, Chetan Mehta ORCID, Akhil Suresh ORCID, Usha Y Nayak ORCID, Yogendra Nayak* ORCID
Pharm Sci. 2020;26(Suppl 1): S52-S62. doi: 10.34172/PS.2020.44
Scopus ID: 85097296158    
Article
PDF
XML
Cited By:
3
3
Research Article COVID-19

5. The Integration of Pharmacophore-Based 3D-QSAR Modeling and Virtual Screening in Identification of Natural Product Inhibitors against SARS-CoV-2
Samira Norouzi, Maryam Farahani, Samad Nejad Ebrahimi* ORCID
Pharm Sci. 2021;27(Suppl 1): S94-S108. doi: 10.34172/PS.2020.98
Scopus ID: 85117587296    
Article
PDF
Suppl 1
XML
Cited By:
6
2
Mini Review COVID-19

6. A New Possible Indication of Direct-acting Anti-hepatitis C Drugs in the Therapeutic Management of COVID-19: A Narrative Literature Review
Alireza Mashhadi Hemmatabadi ORCID, Fatemeh Jafari ORCID, Hesamoddin Hosseinjani* ORCID
Pharm Sci. 2021;27(Suppl 1): S78-S85. doi: 10.34172/PS.2021.23
Scopus ID: 85118716133    
Article
PDF
XML
Cited By:
0
1
Review COVID-19

7. The Impact of Vitamin D Supplementation on Mortality Rate and Clinical Outcomes of COVID-19 Patients: A Systematic Review and Meta-Analysis
Leila Nikniaz ORCID, Mohammad Amin Akbarzadeh ORCID, Hossein Hosseinifard ORCID, Mohammad-Salar Hosseini* ORCID
Pharm Sci. 2021;27(Suppl 1): S1-S12. doi: 10.34172/PS.2021.13
Scopus ID: 85115423983    
Article
PDF
Suppl 1
XML
Cited By:
27
13
Mini Review COVID-19

8. Potential Sedative and Therapeutic Value of Dexmedetomidine in Critical COVID-19 Patients
Saeid Safari* ORCID, Alireza Jahangirifard, Alireza Zali, Alireza Salimi, Ehsan Bastanhagh, Reza Aminnejad, Reza Jalili Khoshnood, Davood Ommi
Pharm Sci. 2021;27(Suppl 1): S86-S93. doi: 10.34172/PS.2021.26
Scopus ID: 85118708526    
Article
PDF
XML
Cited By:
1
0
Review COVID-19

9. Potential Roles of Vitamins in the Management of COVID-19: A Comprehensive Review
Homa Rezaei ORCID, Sajad Khiali ORCID, Hadis Rezaei, Haleh Rezaee, Hossein Bannazadeh Baghi, Matin Pourghasem, Taher Entezari-Maleki* ORCID
Pharm Sci. 2021;27(Suppl 1): S29-S49. doi: 10.34172/PS.2021.41
Scopus ID: 85118747204    
Article
PDF
XML
Cited By:
3
0
Review COVID-19

10. Acyclovir as a Potential Add-on Therapy in COVID-19 Treatment Regimens
Fatemeh Heidary* ORCID, Sedigheh Madani, Reza Gharebaghi* ORCID, Fahimeh Asadi-amoli
Pharm Sci. 2021;27(Suppl 1): S68-S77. doi: 10.34172/PS.2021.38
Scopus ID: 85118758701    
Article
PDF
XML
Cited By:
11
6

   Indexing & Abstracting: